SANOFI VACCINES CANADA LTD.
Registration:
12
of
12
(2026-01-12
to
present)
Details Regarding the Identified Subject Matter
|
Specific Topics of Lobbying Communications
|
Intended Outcomes
|
Associated Subject Matters
|
Create an opportunity for a new product to be included in the Provincial Respiratory Syncytial Virus program to provide infants in BC with enhanced protection against this virus
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health
|
Discuss Corporate investment (infrastructure, clinical trials etc.) in the province in the context of the Life Sciences Sector
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Science and Technology
|
Establishment of an influenza vaccination program for Seniors (65+) in British Columbia utilizing Fluzone® High-Dose, a Sanofi Pasteur product
|
Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Health, Senior Citizens
|